Chronic News and Research

RSS

Pulsed-dye laser surgery for voice disorders better all round

The newly developed pulsed-dye laser surgery for voice disorders has been found to be faster, cheaper, better tolerated, and less complicated than standard surgery that requires general anesthesia, more time and a longer recovery, surgeons reported here today at an international conference on problems associated with laryngopharyngeal reflux.

21 May 2004

Pacemaker-type device and medicines reduce hospital stays and death rates

A nationwide clinical trial of more than 1,600 heart failure patients showed that when medicines are combined with the use of a pacemaker-type device that resynchronizes both sides of the heart, hospital stays and death rates drop significantly.

20 May 2004

Improving the care delivered to children with special health care needs

Health care delivered close to home is vitally important, especially when the patient is a child. But how do community pediatric practices adapt to offer the best care when faced with a child who has complex and often, multiple health needs? Reporting in this month's issue of Pediatrics, Dartmouth researchers outline a process designed to help any practice become a state of the art "medical home" for such children.

20 May 2004

Causes of hepatitis and potential therapies that may improve care presented in study

Hepatitis, a potentially serious disease caused by a virus that attacks the liver, is a major problem worldwide. Hepatitis A is generally food-borne, while hepatitis B and C spread primarily through parenteral or sexual routes. Hepatitis B and C can be life-long, potentially deadly chronic infections.

19 May 2004

Caffeinated beverages may benefit some people who are at high-risk for liver disease

According to new research presented today at Digestive Disease Week, drinking caffeinated beverages may benefit some people who are at high-risk for liver disease. Conversely, a study by researchers from India found that soda drinkers, who represent a huge percentage of the American population, may actually have an increased risk of developing esophageal cancer.

19 May 2004

CRT implantable defibrillators significantly reduce hospitalization rates and extend lives

Researchers at the University of Colorado Health Sciences Center have announced the findings of a large-scale clinical trial for patients with late-stage heart failure. Results showed that cardiac resynchronization therapy (CRT) from implantable pacemaker-like devices or CRT combined with an implantable defibrillator (CRT-D), when used in addition to optimal drug therapy, reduced significantly the mortality and first hospitalization rate when compared to drug therapy alone. CRT-D also substantially lowered mortality.

19 May 2004

Network formed to tackle potentially fatal reaction to smallpox vaccine

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), launched the Atopic Dermatitis and Vaccinia Network (ADVN), a nationwide research group that seeks to reduce the risk of eczema vaccinatum (EV), a severe and potentially deadly complication of smallpox immunization.

19 May 2004

$20.7 million to make smallpox vaccine safer

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a five-year, $20.7 million grant to National Jewish Medical and Research Center to lead a consortium of academic medical centers trying to make smallpox vaccines safer for millions of people with atopic dermatitis, also known as eczema.

19 May 2004

Financially burdened patients more likely to die after coronary revascularization

Heart patients who had angioplasty or bypass surgery and felt burdened by medical costs were more than twice as likely to die within a year of their procedure as patients who didn’t have trouble paying for healthcare, according to a study presented today at the American Heart Association’s 5th annual Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.

19 May 2004

New book highlights pros and cons of medical use of cannabis

A new book which brings together the relevant science regarding the beneficial effects of cannabis for identified medical conditions and explains many harmful side effects has been launched at Australia's Southern Cross University today.

19 May 2004

Benitec acquires Avocel to focus on rapid development of hepatitis C therapeutics

Benitec Ltd. today announced the acquisition of Avocel, Inc. of Sunnyvale, CA, a leading RNAi therapeutics company, and the establishment of its wholly-owned US subsidiary, Benitec, Inc. Through the acquisition, Benitec gains its first in-house advanced therapeutic development program using DNA-directed RNAi (ddRNAi) to target the Hepatitis C virus.

18 May 2004

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Centocor, Inc., and Schering-Plough Corporation announced today the initiation of the SONIC (Study of Immunomodulator Naive patients in Crohn's Disease) trial that will evaluate the efficacy of REMICADE® (infliximab) versus azathioprine, a conventional immunosuppressive agent, alone and versus the combination of both drugs for the treatment of patients with Crohn's disease.

18 May 2004

First filing for zoledronic acid in metabolic bone disease

One 15-minute infusion of the intravenous bisphosphonate zolendronic acid more rapidly reduced the biochemical markers of bone turnover in patients with Paget's disease than was seen in a head-to-head comparison with the oral treatment risedronate (95% vs. 75% response rate).

17 May 2004

Facts about prevalence of arthritis in the U.S.A

Arthritis is the leading cause of physical disability in the United States. Arthritis comprises over 100 different disease and conditions. The most common are osteoarthritis, rheumatoid arthritis, fibromyalgia, and gout.

15 May 2004

CDC announces new goals and organizational structure

Centers for Disease Control and Prevention (CDC) Director Dr. Julie Gerberding announced today new goals and integrated operations that will allow the federal public health agency to have greater impact on the health of people around the world.

15 May 2004

Genetically engineered viruses may create new class of cancer therapies

A genetically engineered virus can selectively kill cancerous cells in the lung and colon while leaving healthy cells intact, according to new research published today in Cancer Research by William Wold and colleagues at Saint Louis University School of Medicine.

15 May 2004

Chronic News and Research

Pulsed-dye laser surgery for voice disorders better all round

Pacemaker-type device and medicines reduce hospital stays and death rates

Improving the care delivered to children with special health care needs

Causes of hepatitis and potential therapies that may improve care presented in study

Caffeinated beverages may benefit some people who are at high-risk for liver disease

CRT implantable defibrillators significantly reduce hospitalization rates and extend lives

Network formed to tackle potentially fatal reaction to smallpox vaccine

$20.7 million to make smallpox vaccine safer

Financially burdened patients more likely to die after coronary revascularization

New book highlights pros and cons of medical use of cannabis

Benitec acquires Avocel to focus on rapid development of hepatitis C therapeutics

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

First filing for zoledronic acid in metabolic bone disease

Facts about prevalence of arthritis in the U.S.A

CDC announces new goals and organizational structure

Genetically engineered viruses may create new class of cancer therapies

Screening for liver diseases benefits outweigh costs for some, but not all, conditions

People with pre-diabetes can make changes to prevent serious illness

Study of hematopoietic stem cell transplantation for severe, treatment-resistant lupus

Minority women are disproportionately impacted by the autoimmune disease lupus

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News